Víctor Marcos-Garcés

Dr. Víctor Marcos-Garcés

Department of Cardiology, Hospital Clínico Universitario de Valencia, Valencia, Spain
+1
orcid
Cardiology Consultant. Emerging Researcher

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2014 in Journal of Anatomy
Verified
Journal Article
Closed access
PDF file
Víctor Marcos-GarcésVíctor Marcos-Garcés
Víctor Marcos-Garcés
PAP. Molina Aguilar
P. Molina Aguilar
CBCarlos Bea
Carlos Bea
VGVíctor Garcia-Bustos
Víctor Garcia-Bustos
JSJ. Benavent Seguí
J. Benavent Seguí
Amparo Ruiz-SauríAmparo Ruiz-Saurí
Amparo Ruiz-Saurí

1 August 2020 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
Víctor Marcos-GarcésVíctor Marcos-Garcés
Víctor Marcos-Garcés
JGJose Gavara
Jose Gavara
JMJose V. Monmeneu
Jose V. Monmeneu
MLMaria P. Lopez-Lereu
Maria P. Lopez-Lereu
MBMaria J. Bosch
Maria J. Bosch
VBVicente Bodi
Vicente Bodi

20 March 2017 in Journal of Microscopy
Verified
Journal Article
Closed access
PDF file
Víctor Marcos-GarcésVíctor Marcos-Garcés
Víctor Marcos-Garcés
MHM. Harvat
M. Harvat
PAP. Molina Aguilar
P. Molina Aguilar
AIA. Ferrández Izquierdo
A. Ferrández Izquierdo
Amparo Ruiz-SauríAmparo Ruiz-Saurí
Amparo Ruiz-Saurí

1 December 2020 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
Víctor Marcos-GarcésVíctor Marcos-Garcés
Víctor Marcos-Garcés
JGJose Gavara
Jose Gavara
MLMaria P. Lopez-Lereu
Maria P. Lopez-Lereu
JMJose V. Monmeneu
Jose V. Monmeneu
CRCesar Rios-Navarro
Cesar Rios-Navarro
VBVicente Bodi
Vicente Bodi
Background: Cardiac magnetic resonance (CMR) permits robust risk stratification of discharged ST-segment–elevation myocardial infarction patients, but its indiscriminate use in all cases is not feasible. We evaluated the utility of left ventricular ejection fraction (LVEF) by echocardiography for a selective use of CMR after ST-segment–elevation myocardial infarction. Methods: Echocardiography and CMR were performed in 1119 patients discharged for ST-segment–elevation myocardial infarction included in a multicenter registry. The prognostic power of CMR beyond echocardiography-LVEF was assessed using adjusted C statistic, net reclassification improvement index, and integrated discrimination improvement index. Results: During a 4.8-year median follow-up, 136 (12%) first major adverse cardiac events (MACE) occurred (47 cardiovascular deaths and 89 readmissions for acute heart failure). In the entire group, CMR-LVEF (but not echocardiography-LVEF) independently predicted MACE occurrence. The MACE rate significantly increased only in patients with CMR-LVEF<40% (≥50%: 7%, 40%–49%: 9%, <40%: 27%, P <0.001). Most patients displayed echocardiography-LVEF≥50% (629, 56%), and they had a low MACE rate (57/629, 9%). In patients with echocardiography-LVEF<50% (n=490, 44%), the MACE rate was also low in those with CMR-LVEF≥40% (24/278, 9%) but significantly increased in patients with CMR-LVEF<40% (55/212, 26%; P <0.001). Compared with echocardiography-LVEF, CMR-LVEF significantly improved MACE prediction in the group of patients with echocardiography-LVEF<50% (C statistic, 0.80 versus 0.72; net reclassification improvement index, 0.73; integrated discrimination improvement index, 0.10) but not in those with echocardiography-LVEF≥50% (C statistic 0.66 versus 0.66; net reclassification improvement index, 0.17; integrated discrimination improvement index, 0.01). Conclusions: A straightforward strategy based on a selective use of CMR for risk prediction in ST-segment–elevation myocardial infarction patients with echocardiography-LVEF<50% can provide insights into patient care. The cost-effectiveness of this approach, as well as the direct implications in clinical management, should be further explored.

1 July 2017 in Pathology and Oncology Research
Verified
Journal Article
Closed access
PDF file
Amparo Ruiz-SauríAmparo Ruiz-Saurí
Amparo Ruiz-Saurí
VGVíctor Garcia-Bustos
Víctor Garcia-Bustos
EGE. Granero
E. Granero
SCS. Cuesta
S. Cuesta
MSM. A. Sales
M. A. Sales
ALA. Llombart-Bosch
A. Llombart-Bosch

Verified
Journal Article
Open access
PDF file
Víctor Marcos-GarcésVíctor Marcos-Garcés
Víctor Marcos-Garcés
CBCarlos Bertolín Boronat
Carlos Bertolín Boronat
HMHector Merenciano-Gonzalez
Hector Merenciano-Gonzalez
MMMaría.Luz Martínez Mas
María.Luz Martínez Mas
JAJosefa Inés Climent Alberola
Josefa Inés Climent Alberola
VBVicente Bodi
Vicente Bodi
Despite the improvement in prognosis in patients with acute myocardial infarction (AMI), a significant proportion of survivors still experience heart failure (HF)-related adverse outcomes. Adverse left ventricular remodeling (LVR), which refers to a progressive dilation of left ventricular (LV) end-diastolic and end-systolic volumes, usually accompanied by a deterioration in LV systolic function, occurs frequently and underlies most cases of HF development after AMI. In this review, we discuss the current definitions of post-AMI LVR, the most appropriate imaging modalities for its detection, and the pathophysiological mechanisms by which Cardiac Rehabilitation (CR) can improve LVR—including exercise interventions, cardiovascular risk factors control, and pharmacological therapy optimization. Finally, we provide up-to-date recommendations for the follow-up and management of LVR in post-AMI patients enrolled in CR and outline future prospects on this topic.